Suven Pharmaceuticals Limited (SUVENPHAR.NS) NSE

1,078.00

-1.2(-0.11%)

Updated at May 16, 2025 03:30PM

Currency In INR

Valuation

Market Cap270.32B
Enterprise Value272.26B
P/E Ratio102.56
PEG Ratio-20.47
Price/Sales Ratio34.44
Price/Book Ratio15.99
Enterprise/Revenue34.6
Enterprise/EBITDA99.7

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.22
Operating Margin0.27

Management Effectiveness

Return On Assets0.09
Return On Equity0.14

Income Statement

Revenue11.98B
Revenue/Share47.58
Gross Profit8.92B
EBITDA4.34B
Net Income2.65B
Diluted EPS10.45

Balance Sheet

Total Cash2.9B
Total Cash/Share11.54
Total Debt2.79B
Total Debt/Equity0.16
Current Ratio2.43
Book Value Per Share73.13

Price History

52-Week Change44.03
52-Week High1,360
52-Week Low598
Moving Average 50 Days1,130.01
Moving Average 200 Days1,155.58

Statistics

Average Volume295,426
Shares Outstanding382.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 25, 2020